[1]
“DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION: KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021005 , Jan. 2021, doi: 10.4084/mjhid.2021.005.